Supplementary Figures including Figure legends from Lapatinib Resistance in Breast Cancer Cells Is Accompanied by Phosphorylation-Mediated Reprogramming of Glycolysis

Figure S1. Quality of phospho(proteomic) dataset acquired. Figure S2. (Phospho)proteomic analysis of lapatinib mode of action in parental cells. Figure S3. Signaling reprogramming in lapatinib resistance. Figure S4. Identification of pharmacologically actionable targets and phenotypes based on a breast cancer model of lapatinib resistance. Figure S5. Metabolic changes in lapatinib resistant cell line model.